1. Home
  2. Live Updates
  3. New covid vaccine

Live Breaking News & Updates on New covid vaccine

Stay informed with the latest breaking news from New covid vaccine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in New covid vaccine and stay connected to the pulse of your community

What is the RS2 New Indian Covid Vaccine That May Fight All Strains of Coronavirus?

A team of Indian scientists are working on a new Covid-19 vaccine that may help against potential future strains as well. Here is what we know so far about this new vaccine. - What is the RS2 New Indian Covid Vaccine That May Fight All Strains of Coronavirus?

India , Nidhi-mittal , Raghavan-varadarajan , Indian-institute-of-science-iisc , Covid-vaccine , New-covid-vaccine , Indian-institute , Molecular-biophysics-unit , Receptor-binding-domain , Covid-cases-in-india , Covid-jn-1 , Covid-19

FDA Approves Novavax's New Covid Vaccine Designed To Protect Against The Latest Strain

At the recommendation of the FDA, the new boosters protect against XBB variants, which made up 95% of all U.S. Covid cases in June.

World-health-organization , Bridge-program , Drug-administration , Centers-for-disease , Pfizer , Disease-control , Okay-to-get-your-covid , Flu-and , Experts-say , Xbb , Covid

Is the US Getting a New Covid vaccine?

The US is expected to receive a new COVID-19 vaccine in fall 2023. The vaccine will be updated to target the Omicron variant and is expected to be more effective against COVID-19 than current vaccines.


United-states , Americans , Centers-for-disease , Pfizer , Drug-administration , Disease-control , Emergency-use-authorization , Should-get , New-covid-vaccine , New-vaccine ,

FDA May Approve New Covid Boosters By Friday As Deaths Spike, Report Says

At the recommendation of the FDA, the new boosters protect against XBB variants, which made up 95% of all U.S. Covid cases in June.

Bridge-program , Drug-administration , A-centers-for-disease , Pfizer , World-health-organization , Disease-control , Okay-to-get-your-covid , Flu-and , Experts-say , Xbb , Covid

Omicron coronavirus variant XBB.1.5 more likely to infect those who are vaccinated: Report [Details]

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) informed earlier this week that India has so far reported 26 cases of the Omicron XBB.1.5 variant

New-york , United-states , Delhi , India , Adar-poonawalla , Twitter , Department-of-health , World-health-organization , Us-centers-for-disease , Genomics-consortium , New-york-city , Mental-hygiene

Major setback, AstraZeneca's nasal spray Covid vaccine fails in early trial

Covid-19: The University of Oxford, in an official statement, said that the antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in the first of usually three phases of clinical testing.

University-of-oxford , Astrazeneca-covid-vaccine , Nasal-spray-trial-of-covid-vaccine , Nasal-spray-covid-vaccine , New-covid-vaccine ,

FDA advisers recommend updating COVID-19 booster shots for fall

A Food and Drug Administration advisory panel recommends that COVID-19 vaccines should get an updated formula for the fall.

Centers-for-disease , Pfizer , Drug-administration , Disease-control , New-covid-vaccine , Omicron-covid-vaccine , Omicron-vaccine ,

FDA to consider future COVID-19 vaccines

The FDA notes that while the original vaccine doesn’t offer as much protection against low-level infections, it remains effective at stopping severe COVID-19 illness.

Pfizer , Drug-administration , New-covid-vaccine , Omicron-covid-vaccine , Omicron-vaccine ,

FDA advisers recommend updating COVID-19 booster shots for fall

A Food and Drug Administration advisory panel recommends that COVID-19 vaccines should get an updated formula for the fall.

Centers-for-disease , Pfizer , Drug-administration , Disease-control , New-covid-vaccine , Omicron-covid-vaccine , Omicron-vaccine ,

Sanofi, Glaxo's new Covid vaccine shows 100% efficacy against severe disease

Sanofi and GlaxoSmithKline Plc, the pharma giants that stumbled in the race to develop a Covid-19 shot, found their vaccine protects against severe disease and hospitalization and will submit data to regulators for clearance.

Glaxosmithkline-plc , Sanofi , Glaxo , New-covid-vaccine , Sanofi-covid-vaccine , Glaxo-covid-vaccine , Glaxosmithkline , Sanofi-gsk-vaccine , Sanofi-gsk-covid-vaccine ,